“This is a particularly promising result given the current lack of effective treatments against liver tumors, which is the third leading cause of cancer death in the United States,” said lead researcher Guangfu Li.
According to the Medical Express website, the treatment includes a tumor-suppressing lipid molecule C6-ceramide nanoliposome (LipC6) and an antibody called CTLA4. When used together in this study, the combination significantly slowed tumor growth.
Not every component of the mixture was effective in fighting liver cancer alone, but the response was strong when a combination of the two was used.
Since the ingredients in the treatment have previously been approved by the US Food and Drug Administration, the mixture is expected to reach the stage of human application soon.
Related posts:
The new realme GT Neo 3 will have a 120Hz touchscreen with a touch sampling rate of 1000Hz.
This 45-year-old single malt comes in a bottle that looks more like a perfume.
Shaymin arrives in Pokémon Sparkling Diamond and Sparkling Pearl
A first look at the gameplay of Horizon: Call of the Mountain
He creates flying karts that can rise 2 meters from the ground
The first version of the virtual planetarium Stellarium has been released - it has been developed fo...
Skyrim: 30 facts you didn't know about the latest Elder Scrolls
Call of Duty MW3: the majority of upcoming maps will not be recycled | Xbox One